[Polychemotherapy of Hodgkin's lymphoma. 3. Stage IV].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001792:Blood Platelets / Q000187:drug effects; D004338:Drug Combinations; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004338:Drug Combinations; D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D011241:Prednisone
La plichemioterapia del linfoma di Hodgkin. 3. IV stadio.